BIOS BioPlus Acquisition Corporation

BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its first quarter 2017 financial results on Thursday, May 4, 2017, before the opening of the U.S. financial markets.

Daniel E. Greenleaf, President and Chief Executive Officer, and Jeffrey M. Kreger, Senior Vice President, Chief Financial Officer and Treasurer, will conduct a conference call as follows:

Date	Thursday, May 4, 2017
Time	9:00 a.m. EDT
Toll free (U.S.)	(888) 372-9592
Webcast (live and replay)	www.bioscrip.com

A replay of the conference call will be available for two weeks after the call's completion by dialing (855) 859-2056 (US) and entering conference call ID number 8579499.

About BioScrip, Inc.BioScrip, Inc. is a leading national provider of infusion and home healthcare management solutions. BioScrip partners with healthcare providers, including physicians, hospital systems, skilled nursing facilities, and with healthcare payors to provide patients better access to high quality, efficient post-acute care services. BioScrip operates with a commitment to bring infusion therapy services into the home or alternate-site settings. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Contacts:

Jeffrey M. Kreger
Chief Financial Officer
T: (720) 697-5200
jeffrey.kreger@bioscrip.com

David Clair
ICR, Inc.
T: (646) 277-1266
david.clair@icrinc.com